Anebulo Pharmaceuticals, Inc.
ANEB
Rank in Stocks
#28249
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages... Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company’s lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Share Price
$0.29
Last synced: 2026-11-09
Market Cap
$11.83M
Change (1 day)
5.45%
Change (1 year)
-87.61%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Anebulo Pharmaceuticals, Inc. (ANEB)
Category
Healthcare
EPS for Anebulo Pharmaceuticals, Inc. (ANEB)
EPS as of December 2025 TTM: $-0.19
According to Anebulo Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $-0.19. At the end of 2025 the company had an EPS of $-0.25, an increase over its 2024 EPS of $-0.32.
EPS history for Anebulo Pharmaceuticals, Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.19 | -24.00% |
| 2025 | $-0.25 | -21.88% |
| 2024 | $-0.32 | -31.91% |
| 2023 | $-0.47 | 62.07% |
| 2022 | $-0.29 | -77.69% |
| 2021 | $-1.30 | 17,467.57% |
| 2020 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -8,342.11% |
US
|
|
| $-7.07 | 3,621.05% |
US
|
|
| $-5.29 | 2,684.21% |
AU
|
|
| $12.88 | -6,879.00% |
BE
|
|
| $21.56 | -11,447.37% |
NL
|
Questions about Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS)
What is Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS)?
Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $-0.19, as of Dec 2025.
What was Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS) was $-0.25, compared with $-0.32 in 2024.
How has Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.01) and lowest in 2021 ($-1.30).
How does Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Anebulo Pharmaceuticals, Inc.'s earnings per share (EPS) ($-0.19) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.